The Peptidyl-Prolyl cis-trans isomerase, Pin1, associates with Protein Kinase C θ via a critical Phospho-Thr-Pro motif in the V3 regulatory domain

Protein kinase C-θ (PKCθ) is a member of the novel PKC subfamily known for its selective and predominant expression in T lymphocytes where it regulates essential functions required for T cell activation and proliferation. Our previous studies provided a mechanistic explanation for the recruitment of...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 14; p. 1126464
Main Authors Anto, Nikhil Ponnoor, Muraleedharan, Amitha, Nath, Pulak Ranjan, Sun, Zuoming, Keasar, Chen, Livneh, Etta, Braiman, Alex, Altman, Amnon, Kong, Kok-Fai, Isakov, Noah
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Protein kinase C-θ (PKCθ) is a member of the novel PKC subfamily known for its selective and predominant expression in T lymphocytes where it regulates essential functions required for T cell activation and proliferation. Our previous studies provided a mechanistic explanation for the recruitment of PKCθ to the center of the immunological synapse (IS) by demonstrating that a proline-rich (PR) motif within the V3 region in the regulatory domain of PKCθ is necessary and sufficient for PKCθ IS localization and function. Herein, we highlight the importance of Thr -Pro residue in the PR motif, the phosphorylation of which is key in the activation of PKCθ and its subsequent IS localization. We demonstrate that the phospho-Thr -Pro motif serves as a putative binding site for the peptidyl-prolyl isomerase (PPIase), Pin1, an enzyme that specifically recognizes peptide bonds at phospho-Ser/Thr-Pro motifs. Binding assays revealed that mutagenesis of PKCθ-Thr -to-Ala abolished the ability of PKCθ to interact with Pin1, while Thr replacement by a Glu phosphomimetic, restored PKCθ binding to Pin1, suggesting that Pin1-PKCθ association is contingent upon the phosphorylation of the PKCθ-Thr -Pro motif. Similarly, the Pin1 mutant, R A, failed to associate with PKCθ, suggesting that the integrity of the Pin1 N-terminal WW domain is a requisite for Pin1-PKCθ interaction. docking studies underpinned the role of critical residues in the Pin1-WW domain and the PKCθ phospho-Thr -Pro motif, to form a stable interaction between Pin1 and PKCθ. Furthermore, TCR crosslinking in human Jurkat T cells and C57BL/6J mouse-derived splenic T cells promoted a rapid and transient formation of Pin1-PKCθ complexes, which followed a T cell activation-dependent temporal kinetic, suggesting a role for Pin1 in PKCθ-dependent early activation events in TCR-triggered T cells. PPIases that belong to other subfamilies, i.e., cyclophilin A or FK506-binding protein, failed to associate with PKCθ, indicating the specificity of the Pin1-PKCθ association. Fluorescent cell staining and imaging analyses demonstrated that TCR/CD3 triggering promotes the colocalization of PKCθ and Pin1 at the cell membrane. Furthermore, interaction of influenza hemagglutinin peptide (HA )-specific T cells with antigen-fed antigen presenting cells (APCs) led to colocalization of PKCθ and Pin1 at the center of the IS. Together, we point to an uncovered function for the Thr -Pro motif within the PKCθ-V3 regulatory domain to serve as a priming site for its activation upon phosphorylation and highlight its tenability to serve as a regulatory site for the Pin1 isomerase.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Daniel Krappmann, Helmholtz Center München, Helmholtz Association of German Research Centres (HZ), Neuherberg, Germany; Ricardo A. Fernandes, University of Oxford, United Kingdom
Edited by: Sutatip Pongcharoen, Naresuan University, Thailand
Present addresses: Amitha Muraleedharan, Centre d’Excellence en Recherche sur les Maladies Orphelines-Fondation Courtois (CERMO-FC) and Biological Sciences Department, Université du Québec à Montréal (UQAM), Montréal, QC, Canada; Pulak Ranjan Nath, Lentigen Technology Inc., A Miltenyi Biotec Company, Gaithersburg, MD, United States
This article was submitted to T Cell Biology, a section of the journal Frontiers in Immunology
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2023.1126464